Clinical trial
"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00201994 · Otsuka Pharmaceutical Development & Commercialization, Inc., Industry · Completed
Key facts
| NCT number | NCT00201994 |
|---|---|
| Title | "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia |
| Official title | Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2 |
| Lead sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc., Industry |
| Collaborators | Otsuka Pharmaceutical Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyponatremia, Water Intoxication, Inappropriate ADH Syndrome, Water-electrolyte Imbalance |
| Intervention type | Drug |
| Interventions | Tolvaptan |
| Enrollment | 243 |
| Start date | Nov 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | May 3, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: